Rights and permissions
About this article
Cite this article
Rivastigmine [‘Exelon’] improves QOL for Alzheimer’s disease. Pharmacoecon. Outcomes News 241, 11 (1999). https://doi.org/10.1007/BF03275270
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03275270